Rising Incidence of Non-Cardia Gastric Cancer among Young Women in the United States, 2000–2018: A Time-Trend Analysis Using the USCS Database

Simple Summary Although the global incidence of non-cardia gastric cancer (NCGC) is decreasing, there are limited data on sex-specific incidence in the U.S. The aim of our study was to investigate age and sex-specific time trends of NCGC incidence using a large national database from the Surveillance, Epidemiology, and End Results (SEER) Program, and thereafter to externally validate these findings within an independent population-based database, the National Program of Cancer Registries (NPCR). We evaluated the influence of race, histopathology, and disease stage at diagnosis on these trends. NCGC incidence has been relatively increasing at a greater rate in younger women compared to counterpart men over the last two decades, and this rise may be explained by a disproportionate increase in young non-Hispanic White women. Our findings support the increasing incidence of cancers at multiple sites in young women, and emphasize the need for dedicated research to determine the etiologies of these alarming trends. Abstract Introduction: Although the global incidence of non-cardia gastric cancer (NCGC) is decreasing, there are limited data on sex-specific incidence in the United States. This study aimed to investigate time trends of NCGC from the SEER database to externally validate findings in a SEER-independent national database, and to further assess trends among subpopulations. Methods: Age-adjusted incidence rates of NCGC were obtained from the SEER database from 2000 to 2018. We used joinpoint models to calculate average annual percentage change (AAPC) to determine sex-specific trends among older (≥55 years) and younger adults (15–54 years). Using the same methodology, findings were then externally validated using SEER-independent data from the National Program of Cancer Registries (NPCR). Stratified analyses by race, histopathology, and staging at diagnosis were also conducted in younger adults. Results: Overall, there were 169,828 diagnoses of NCGC from both independent databases during the period 2000–2018. In SEER, among those <55 years, incidence increased at a higher rate in women (AAPC = 3.22%, p < 0.01) than men (AAPC = 1.51%, p = 0.03), with non-parallel trends (p = 0.02), while a decreasing trend was seen in both men (AAPC = −2.16%, p < 0.01) and women (AAPC = −1.37%, p < 0.01) of the ≥55 years group. Validation analysis of the SEER-independent NPCR database from 2001 to 2018 showed similar findings. Further stratified analyses showed that incidence is disproportionately increasing in young non-Hispanic White women [AAPC = 2.28%, p < 0.01] while remaining stable in their counterpart men [AAPC = 0.58%, p = 0.24] with non-parallel trends (p = 0.04). This pattern was not observed in other race groups. Conclusion: NCGC incidence has been increasing at a greater rate in younger women compared to counterpart men. This disproportionate increase was mainly seen in young non-Hispanic White women. Future studies should investigate the etiologies of these trends.

[1]  H. El‐Serag,et al.  Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention , 2023, Nature Reviews Clinical Oncology.

[2]  Katherine S. Garman,et al.  Differences in Helicobacter pylori Prevalence by Race , 2022, Gastro Hep Advances.

[3]  J. de Batlle,et al.  Evolution of the consumption trend of proton pump inhibitors in the Lleida Health Region between 2002 and 2015 , 2022, BMC Public Health.

[4]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[5]  D. Albanes,et al.  Association of Antiparietal Cell and Anti-Intrinsic Factor Antibodies With Risk of Gastric Cancer , 2021, JAMA oncology.

[6]  G. Hold,et al.  The Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment: Chance or Curse? , 2021, Cellular and molecular gastroenterology and hepatology.

[7]  Kevin M. Waters,et al.  Disparities and survival in newly diagnosed gastric cancer in Hispanic patients in the United States: a propensity score matched analysis. , 2021, Journal of gastrointestinal oncology.

[8]  D. Shin,et al.  Association of the Frequency and Quantity of Alcohol Consumption With Gastrointestinal Cancer , 2021, JAMA network open.

[9]  A. Stengel,et al.  Influencing Factors and Effects of Treatment on Quality of Life in Patients With Gastric Cancer—A Systematic Review , 2021, Frontiers in Psychiatry.

[10]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[11]  R. Kelly,et al.  Healthcare utilization and total costs of care among patients with advanced metastatic gastric and esophageal cancer. , 2020, Future oncology.

[12]  Shaohua Xie,et al.  Sex difference in the incidence of cardia and non-cardia gastric cancer in the United States, 1992–2014 , 2020, BMC Gastroenterology.

[13]  Mu Yang,et al.  Statistics and pitfalls of trend analysis in cancer research: a review focused on statistical packages , 2020, Journal of Cancer.

[14]  A. Bruni,et al.  Effects of listening to music in digestive endoscopy: A prospective intervention study led by nursing. , 2020, Journal of advanced nursing.

[15]  H. Howe North American Association of Central Cancer Registries , 2020, Definitions.

[16]  Rebecca D. Kehm,et al.  40 Years of Change in Age- and Stage-Specific Cancer Incidence Rates in US Women and Men , 2019, JNCI cancer spectrum.

[17]  R. Passalacqua,et al.  Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches , 2018, Cellular and Molecular Life Sciences.

[18]  R. Passalacqua,et al.  Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches , 2018, Cellular and Molecular Life Sciences.

[19]  P. Rosenberg,et al.  The Changing Face of Noncardia Gastric Cancer Incidence Among US Non-Hispanic Whites , 2018, Journal of the National Cancer Institute.

[20]  J. Pisegna,et al.  Autoimmune atrophic gastritis: current perspectives , 2017, Clinical and experimental gastroenterology.

[21]  R. Nelson,et al.  A rising trend in the incidence of advanced gastric cancer in young Hispanic men , 2017, Gastric Cancer.

[22]  S. Ishaq,et al.  Helicobacter pylori and gastric cancer: a state of the art review , 2015, Gastroenterology and hepatology from bed to bench.

[23]  A. Meloni-Ehrig,et al.  Gastric cancer: Classification, histology and application of molecular pathology. , 2012, Journal of gastrointestinal oncology.

[24]  P. Rosenberg,et al.  Age-specific trends in incidence of noncardia gastric cancer in US adults. , 2010, JAMA.

[25]  Nayoung Kim,et al.  Stomach Cancer Risk in Gastric Cancer Relatives: Interaction Between Helicobacter pylori Infection and Family History of Gastric Cancer for the Risk of Stomach Cancer , 2010, Journal of clinical gastroenterology.

[26]  Douglas Midthune,et al.  Modeling Reporting Delays and Reporting Corrections in Cancer Registry Data , 2005 .

[27]  Binbing Yu,et al.  Comparability of Segmented Line Regression Models , 2004, Biometrics.

[28]  E. Feuer,et al.  Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.

[29]  J. Fraumeni,et al.  Family history and risk of stomach cancer in Italy. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[30]  P. Feder On Asymptotic Distribution Theory in Segmented Regression Problems-- Identified Case , 1975 .